Article thumbnail

Anticipation in Families with Chronic Lymphocytic Leukemia and Other Lymphoproliferative Disorders

By Haneef Awan, Viggo Jønsson, Tom B. Johannesen, Bernt Ly and Geir E. Tjønnfjord

Abstract

Fifty-one parent-offspring pairs with chronic lymphocytic leukemia (CLL) or other lymphoproliferative disorders (nonCLL) such as malignant lymphoma, multiple myeloma, or other types of lymphocytic leukemia than CLL were ascertained independently in 38 families. There were 30 CLL-CLL parent-offspring pairs and 21 pairs with nonCLL in parents and/or in offspring. The median age of onset of disease was 13 years lower in the offspring than in the parents when comparing all 51 pairs (P < 0.001). This difference was mainly caused by a significantly lower age at onset in offspring with parental nonCLL (P < 0.001) where paternal disease was transferred especially to sons, while affected offspring to parents with CLL have the same age at debut of disease than their parents (P = 0.130) and a nearly equal transfer to sons and daughters. The low-malignant follicular small B-cell lymphoma was the predominant diagnosis within nonCLL. Anticipation is pointed out as one likely mechanism behind the lower age at onset of disease in offspring than in parents, even if a part of this difference is ascribed to a generally earlier diagnosis with modern technology in offspring than in parents

Topics: Original Research
Publisher: Libertas Academica
OAI identifier: oai:pubmedcentral.nih.gov:3072649
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2000). A genetic study of Hodgkin’s lymphoma, an estimate of heritability and anticipation based on familial cancer database in Sweden. Hum Genet.
  2. Age of onset evidence for anticipation in familial non-Hodgkin’s lymphoma.
  3. Anticipation in chronic lymphocytic leukaemia.
  4. (1998). Anticipation in familial chronic lymphocytic leukaemia.
  5. (1998). Anticipation in familial Hodgkin lymphoma.
  6. (2000). Anticipation in familial Hodgkin’s lymphoma. Hum Genet.
  7. (2006). Anticipation in families with Hodgkin’s and non-Hodgkin’s lymphoma in their pedigree. Leukemia Lymphoma.
  8. (1996). Anticipation, an old idea in ne genes.
  9. (2006). Autoimmunity in CLL, grave consequences of gravidity? Leuk Lymph.
  10. B-cell clones as early markers for chronic lymphocytic leukemia.
  11. (2003). B-cell monoclonal lymphocytosis and Bcell abnormalities in the setting of familial B-cell CLL. Cytometry, Part B, Clinical Cytometry.
  12. (2007). Birth order pattern in the inheritance of chronic lymphocytic leukaemia and related lymphoproliferative disease. Leuk Lymph.
  13. chronic lymphocytic leukaemia and associated precurser diseases.
  14. Chronic lymphocytic leukaemia genetics overview.
  15. Chronic lymphocytic leukemia.
  16. Chronic lymphocytic leukemia/small lymphocytic lymphoma. In: Jaffe
  17. (2001). Classification of non-Hodgkin´s lymphomas. In: Knowles DM (ed) Neoplastic hematopathology. 2nd Edition. Philadelphia: Lippincott Williams and Wilkins;
  18. Clustering and anticipation for nodular lymphocyte predominance Hodgkin lymphoma within a French Basque kindred.
  19. (2007). Convergent evolution of genomic imprinting in plants and mammals. Trends Genet.
  20. (2005). Diseases of unstable repeat expansion, mechanisms and common principles. Nat Rev Genet.
  21. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin’s lymphomas among relatives of patients with chronic lymphocytic leukemia.
  22. Epigenetic decisions in mammalian germ cells.
  23. (2004). Epigenetic profiling in chronic lymphocytic leukaemia reveals novel methylation tagets. Cancer Res.
  24. (2006). Epigenetics in chronic lymphocytic leukemia. Semin Oncol.
  25. (1996). Evidence for genetic anticipation in non-Mendelian diseases.
  26. Familial aggregation of Hodgkin lymphoma and related tumors.
  27. Familial chronic lymphocytic leukaemia, a survey and review of published studies.
  28. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia, results from the Swedish family-cancer database.
  29. (2007). Family history of hemotopoietic malignancies and risk of non-Hodgkin lymphoma (NHL), a pooled analysis of 10211 cases and 11905 controls from the International Lymphoma Epidemiology Consortium (InterLymph).
  30. Genetic susceptibility to chronic lymphocytic leukemia.
  31. Genomic aberrations and survival in chronic lymphocytic leukaemia.
  32. (1996). Guidelines for the diagnoses and treatment of chronic lymphocytic leukemia, a report from
  33. Hereditary chronic lymphocytic leukemia, an extended family study and litterature review.
  34. Instability of CAG-trinucleiotide repeats in chronic lymphocytic leukemia. Leukemia Lymphoma.
  35. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
  36. (2005). No evidence for anticipation in lymphoproliferative tumors in population-based samples. Cancer Epidemiol Biomarkers Prev.
  37. Repeat instability, mechanisms of dynamic mutations.
  38. Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmocytic lymphoma, Waldenström macroglobulinemia patients, a population based study in Sweden.
  39. (1986). Segregation analysis. Estimation of factors affecting the genetic structure of population, Segregation analysis, Multifactorial inheritance.
  40. (2007). The influence of parental age and gender on anticipation in familial B-cell malignancies. Med Oncol.
  41. Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia.
  42. Unmutated and mutated chronic lymphocytic leukemia derive from self-reactive B cell precursors despite expressing different antibody reactivity.